CVRx (CVRX) Gross Margin Growth (1y) (2021 - 2026)
CVRx (CVRX) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -65.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 610.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -359.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 9.00 |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | 370.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 370.00 |
| Dec 31, 2025 | 303.00 |
| Sep 30, 2025 | 362.00 |
| Jun 30, 2025 | 35.00 |
| Mar 31, 2025 | -149.00 |
| Dec 31, 2024 | -154.00 |
| Sep 30, 2024 | -72.00 |
| Jun 30, 2024 | -12.00 |
| Mar 31, 2024 | 165.00 |
| Dec 31, 2023 | 581.00 |
| Sep 30, 2023 | 557.00 |
| Jun 30, 2023 | 790.00 |
| Mar 31, 2023 | 664.00 |
| Dec 31, 2022 | 587.00 |
| Sep 30, 2022 | 414.00 |
| Jun 30, 2022 | 536.00 |
| Mar 31, 2022 | 703.00 |
| Dec 31, 2021 | -530.00 |
| Sep 30, 2021 | -454.00 |
| Jun 30, 2021 | -163.00 |